Tanvex Biopharma Inc - ESG Rating & Company Profile powered by AI
Scroll down to the bottom of this webpage for potential risks for Tanvex Biopharma Inc based on industry, geography and marketcap. Comprehensive Sustainability assessment of Tanvex Biopharma Inc can be reached by logging in. If you are employed by Tanvex Biopharma Inc and you would like to use your Sustainability rating, please get in touch.
Tanvex Biopharma Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 4.9; made up of an environmental score of 2.0, social score of 6.4 and governance score of 6.4.
4.9
Medium ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| 744 | Sopharma AD | 5.0 | High |
| 744 | vTv Therapeutics Inc | 5.0 | High |
| 764 | Tanvex Biopharma Inc | 4.9 | High |
| 764 | BetterLife Pharma Inc | 4.9 | High |
| 764 | Acerus Pharmaceuticals Corporation | 4.9 | High |
| ... | ... | ... | |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Tanvex Biopharma Inc have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Tanvex Biopharma Inc disclose current and historical energy intensity?
Sign up for free to unlockDoes Tanvex Biopharma Inc report the average age of the workforce?
Sign up for free to unlockDoes Tanvex Biopharma Inc reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Tanvex Biopharma Inc disclose its ethnicity pay gap?
Sign up for free to unlockDoes Tanvex Biopharma Inc disclose cybersecurity risks?
Sign up for free to unlockDoes Tanvex Biopharma Inc offer flexible work?
Sign up for free to unlockDoes Tanvex Biopharma Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Tanvex Biopharma Inc disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Tanvex Biopharma Inc conduct supply chain audits?
Sign up for free to unlockDoes Tanvex Biopharma Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Tanvex Biopharma Inc conduct 360 degree staff reviews?
Sign up for free to unlockDoes Tanvex Biopharma Inc disclose the individual responsible for D&I?
Sign up for free to unlockDoes Tanvex Biopharma Inc disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Tanvex Biopharma Inc disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Tanvex Biopharma Inc disclose water use targets?
Sign up for free to unlockDoes Tanvex Biopharma Inc have careers partnerships with academic institutions?
Sign up for free to unlockDid Tanvex Biopharma Inc have a product recall in the last two years?
Sign up for free to unlockDoes Tanvex Biopharma Inc disclose incidents of discrimination?
Sign up for free to unlockDoes Tanvex Biopharma Inc allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Tanvex Biopharma Inc issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Tanvex Biopharma Inc disclose parental leave metrics?
Sign up for free to unlockDoes Tanvex Biopharma Inc disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Tanvex Biopharma Inc disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Tanvex Biopharma Inc disclose the pay ratio of women to men?
Sign up for free to unlockDoes Tanvex Biopharma Inc support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Tanvex Biopharma Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Tanvex Biopharma Inc reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Tanvex Biopharma Inc involved in embryonic stem cell research?
Sign up for free to unlockDoes Tanvex Biopharma Inc disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Tanvex Biopharma Inc disclose its waste policy?
Sign up for free to unlockDoes Tanvex Biopharma Inc report according to TCFD requirements?
Sign up for free to unlockDoes Tanvex Biopharma Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Tanvex Biopharma Inc disclose energy use targets?
Sign up for free to unlockDoes Tanvex Biopharma Inc disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Tanvex Biopharma Inc have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Tanvex Biopharma Inc
These potential risks are based on the size, segment and geographies of the company.
Tanvex BioPharma, Inc., a biopharmaceutical company, engages in the research, development, manufacture, and sale of biosimilar in Taiwan and the United States. The company focuses on delivering biosimilars which target neutropenia, breast cancer, metastatic colorectal cancer, and psoriasis. Its products pipeline includes TX01 and TX-05 which have completed Phase III clinical trials; TX-04 and TX-16 that are in Phase I clinical trial; and TX-52 and other products which are in pre-clinical trial. The company was formerly known as Ruenvex Biotech, Inc. Tanvex BioPharma, Inc. was incorporated in 2013 and is based in George Town, the Cayman Islands.